SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (261)11/26/1997 6:54:00 PM
From: Tom D  Read Replies (1) of 887
 
I share your sentiments.

My favorite example of a ridiculously-undervalued incredibly-good, early biotech is NFLD. They are only going to completely take over the $5B blood transfusion market in about 3 years and they still have a market cap under $300M. I think their price goes up about 1% per year. I don't have to do a thing about buying it for another year or so because the price doesn't go irreversibly up until a month before the preliminary advisory committee meetings. I used to think I needed to buy these things before Phase III results were announced, but after getting burned by ABTI, I have concluded that there is inufficient reward for taking the risk.

I can see the appeal of SANG. But, its tough to buy it after watching it double.

After I partly diversify a little bit out of DEPO, I have my sights set on SNUS. You can check out my posting #187 on their thread. I also like HHCA, ADVH and FUSE (the latter while its dirt cheap). I have recent postings on all these threads. I have the dubious distinction of starting the ADVH thread, selling out (to buy DEPO) and then watching my compatriots on the thread suffer through a 50% price collapse for mostly invalid reasons.

TGFD,

Tom D
Thank God for Depo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext